| RS1599569966 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Charcot-Marie-Tooth disease dominant intermediate B |
| RS1599570613 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1599570895 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599571406 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599571722 |
ASXL3
|
Health Risk |
Likely pathogenic |
Marfanoid habitus and intellectual disability, Marfanoid habitus and intellectual disability |
| RS1599572151 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599572831 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599572974 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599573656 |
ASXL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599573759 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, Atypical behavior |
| RS1599574018 |
ASXL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1599575096 |
ASXL3
|
Health Risk |
Likely pathogenic |
— |
| RS1599578081 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS1599616676 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1599617641 |
TBCD
|
Health Risk |
Likely pathogenic |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS1599618968 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1599619080 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1599619180 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1599620408 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease dominant intermediate B |
| RS1599625856 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1599634435 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS1599634685 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Central core myopathy |
| RS1599635569 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1599641280 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1599648136 |
SLC7A9
|
Health Risk |
Likely pathogenic |
Cystine urolithiasis, Cystinuria |
| RS1599649479 |
RYR1
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1599651549 |
PLD3;PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Spinocerebellar ataxia 46 |
| RS1599651726 |
PRX
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease type 4F |
| RS1599652316 |
PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1599655206 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease |
| RS1599656136 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS1599656507 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4F |
| RS1599656851 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1599656972 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease |
| RS1599660141 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1599662669 |
PRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS1599662837 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1599662861 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4F |
| RS1599663316 |
PIGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1599665128 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1599665134 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS1599668553 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS1599669836 |
KMT2B
|
Health Risk |
Likely pathogenic |
— |
| RS1599673988 |
RYR1
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1599674179 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1599674197 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1599676503 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonic disorder, Dystonic disorder |
| RS1599677213 |
KMT2B
|
Health Risk |
Pathogenic |
Specific learning disability, Dystonic disorder |
| RS1599679995 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1599680351 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1599684627 |
SLC7A9
|
Health Risk |
Likely pathogenic |
Cystine urolithiasis, Cystine urolithiasis |
| RS1599687853 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1599688589 |
SLC7A9
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystine urolithiasis, Cystinuria |
| RS1599689373 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1599695744 |
KMT2B
|
Health Risk |
Pathogenic |
Generalized dystonia, Dysarthria |
| RS1599705281 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome |
| RS1599705282 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1599706511 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1599706522 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Alternating hemiplegia of childhood, ATP1A3-associated neurological disorder |
| RS1599706613 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1599712456 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1599712523 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1599715062 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1599715325 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS1599715341 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1599716037 |
RTTN
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism due to RTTN deficiency, Microcephalic primordial dwarfism due to RTTN deficiency |
| RS1599719130 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1599719527 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1599719534 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS1599723609 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1599724778 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS1599725621 |
ATP1A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 12, Hereditary ataxia |
| RS1599726017 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS1599737421 |
NFIX
|
Health Risk |
Pathogenic |
Malan overgrowth syndrome, Marshall-Smith syndrome |
| RS1599737896 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS1599738036 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Malan overgrowth syndrome |
| RS1599738349 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS1599738398 |
NFIX
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfanoid habitus and intellectual disability, Marfanoid habitus and intellectual disability |
| RS1599738608 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS1599744167 |
AXL
|
Health Risk |
Likely pathogenic |
NK-cell enteropathy, NK-cell enteropathy |
| RS1599751192 |
DHX34
|
Health Risk |
Likely pathogenic |
6 conditions, Neurodevelopmental disorders |
| RS1599753508 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS1599759068 |
SPTBN4
|
Health Risk |
Likely pathogenic |
— |
| RS1599759554 |
CALM3
|
Health Risk |
Pathogenic |
Long QT syndrome 16, Long QT syndrome 16 |
| RS1599759598 |
CALM3
|
Health Risk |
Pathogenic |
Long QT syndrome 16, Long QT syndrome 1 |
| RS1599760058 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS1599774265 |
WDR62
|
Health Risk |
Likely pathogenic |
— |
| RS1599784374 |
RFXANK
|
Health Risk |
Pathogenic/Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1599784393 |
RFXANK
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1599794560 |
SPTBN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS1599805729 |
WDR62
|
Health Risk |
Pathogenic |
— |
| RS1599808202 |
GPX4
|
Health Risk |
Likely pathogenic |
— |
| RS1599810980 |
GPX4
|
Health Risk |
Pathogenic |
Spondylometaphyseal dysplasia, Sedaghatian type |
| RS1599814534 |
CEACAM16
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS1599819198 |
SPTBN4
|
Health Risk |
Likely pathogenic |
— |
| RS1599820741 |
ERF
|
Health Risk |
Likely pathogenic |
— |
| RS1599823350 |
ERF
|
Health Risk |
Likely pathogenic |
Lambdoidal craniosynostosis, Lambdoidal craniosynostosis |
| RS1599835856 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1599841026 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS1599842537 |
NLRP12
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cold autoinflammatory syndrome 2, See cases |